ArticleBiomedicines2026
Circulating GDF15 and HbA1c Response to Add-On Exenatide Therapy in Type 2 Diabetes: A Post Hoc Analysis from a Multicenter Trial.
Qi Wu, Kun Yang, Xinyue Liao, Shiyin Zheng, Xiaoyue Zheng, Haining Wang, Jin Yang, Tianpei Hong
Abstract read
In one paragraphArticle in Biomedicines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
Qi WuDepartment of Endocrinology and Metabolism, NHC Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides, Peking University Third Hospital, Beijing 100191, China.
Kun YangDepartment of Endocrinology and Metabolism, NHC Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides, Peking University Third Hospital, Beijing 100191, China.ORCID 0000-0002-7012-4557 Xinyue LiaoDepartment of Endocrinology and Metabolism, NHC Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides, Peking University Third Hospital, Beijing 100191, China.ORCID 0000-0002-2319-2135 Shiyin ZhengDepartment of Endocrinology and Metabolism, NHC Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides, Peking University Third Hospital, Beijing 100191, China.
Xiaoyue ZhengDepartment of Endocrinology and Metabolism, NHC Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides, Peking University Third Hospital, Beijing 100191, China.
Haining WangDepartment of Endocrinology and Metabolism, NHC Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides, Peking University Third Hospital, Beijing 100191, China.
Jin YangDepartment of Endocrinology and Metabolism, NHC Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides, Peking University Third Hospital, Beijing 100191, China.ORCID 0000-0001-6004-955X Tianpei HongDepartment of Endocrinology and Metabolism, NHC Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides, Peking University Third Hospital, Beijing 100191, China.ORCID 0000-0002-5744-5129 Funding
the National Key Research and Development Program of China 2024YFA1802902the National Natural Science Foundation of China 82271611the National Natural Science Foundation of China 82371588the Noncommunicable Chronic Diseases-National Science and Technology Major Project 2023ZD0506901the special fund of the National Clinical Key Specialty Construction Program, P.R, China (2023)
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
glucagon-like peptide-1 agonistsglycated hemoglobingrowth differentiation factor 15type 2 diabetes mellitus
Identifiers
PMID41898219
PMCPMC13024465
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390